Search

Author/Creator Sheikh, Semira

1. A phase 1 study to assess the safety, tolerability, and pharmacokinetics of CXD101 in patients with advanced cancer. Issue 1 (17th October 2018)

Authors:
Eyre, Toby A.; Collins, Graham P.; Gupta, Avinash; Coupe, Nicholas; Sheikh, Semira; Whittaker, John; Wang, Lai Mun; Campo, Leticia; Soilleux, Elizabeth; Tysoe, Finn; Cousins, Richard; La Thangue, Nick; Folkes, Lisa K.; Stratford, Michael R. L.; Kerr, David; Middleton, Mark R.
Journal:
Cancer
Issue:
Volume 125:Issue 1(2019)
Page Start:
99
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

6. Transverse myelitis after anti‐CD19 directed CAR T cell therapy for relapsed large B cell lymphoma. Issue 1 (6th December 2021)

Authors:
Sheikh, Semira; Mokhtari, Sepideh; Silverman, Jeffrey A.; Reid, Kayla; Faramand, Rawan; Davila, Marco L.; Franke, Norman; Locke, Frederick L.; Jain, Michael D.; Wong, Daniel; Kuruvilla, John G.
Journal:
EJHaem
Issue:
Volume 3:Issue 1(2022)
Page Start:
223
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗